Literature DB >> 18105995

Aureomycin therapy in human brucellosis due to Brucella melitensis.

W W SPINK, A I BRAUDE.   

Abstract

Entities:  

Keywords:  AUREOMYCIN; BRUCELLA/melitensis; UNDULANT FEVER/therapy

Mesh:

Substances:

Year:  1948        PMID: 18105995     DOI: 10.1001/jama.1948.02900160013005

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  10 in total

1.  Aureomycin.

Authors:  J CROFTON
Journal:  Postgrad Med J       Date:  1950-07       Impact factor: 2.401

Review 2.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

3.  Encephalomeningitis Due to Brucella Abortus.

Authors:  W W Spink; W H Hall
Journal:  Trans Am Clin Climatol Assoc       Date:  1949

4.  A Study of the Antigen-Antibody Mechanism in Rheumatic Diseases.

Authors:  T M Brown; R H Wichelhausen; W R Merchant; L B Robinson
Journal:  Trans Am Clin Climatol Assoc       Date:  1950

5.  Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.

Authors:  J L Shenep
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

6.  Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.

Authors:  J Cohen; J S McConnell
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

7.  Observations on brucellosis due to Brucella melitensis.

Authors:  W W SPINK
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

8.  From endotoxin to snake venom.

Authors:  W W SPINK
Journal:  Yale J Biol Med       Date:  1958-04

9.  Comment on Hurley, J.C. Towards clinical application of anti-endotoxin antibodies; a re-appraisal of the disconnect. Toxins 2013, 5, 2589-2620.

Authors:  John G Brock-Utne
Journal:  Toxins (Basel)       Date:  2014-04-11       Impact factor: 4.546

10.  Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards clinical application of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Authors:  James C Hurley
Journal:  Toxins (Basel)       Date:  2014-04-11       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.